# Title

 Food and Drugs. PART 107â€”INFANT FORMULA


# ID

 CFR-2018-title21-vol2.Pt. 107


# Structured Analysis Summary

| Type        | Values                                                                                                                     |
|:------------|:---------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['not to exceed', 'maximum', 'more than', 'before', 'after', 'minimum', 'less than', 'at least', 'within', 'no less than'] |
| Duration    | ['1.0 year', '15.0 day', '14.0 day', '24.0 hour', '60.0 day']                                                              |
| Condition   | ['subject to', 'until', 'provided that', 'when', 'not subject to', 'unless', 'if']                                         |
| Entities    | ['Failure', 'Scope', 'Exempt', 'Medicine', 'Food', 'D, and E', 'Nutrition, Labeling', 'Enforcement']                       |
| Date        | ['1986-05-21']                                                                                                             |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                             |
|:--------------|:--------------------------------------------------------------------------------------------------------------------|
| less than     | or a similar statement, if the product contains less than 1 milligram of iron in a quantity of                      |
| before        | Use&#8221;, directions for: (1) Storage of infant formula before and after the container has been opened, including |
| after         | for: (1) Storage of infant formula before and after the container has been opened, including a statement            |
| before        | Use&#8221;, directions for: (1) Storage of infant formula before and after the container has been opened, including |
| before        | Use&#8221;, directions for: (1) Storage of infant formula before and after the container has been opened, including |
| less than     | label directions, will: (1) when consumed, contain not less than the quantity of each nutrient, as set forth        |
| within        | be sold at the retail level, are contained within a multiunit package, the labels of the individual                 |
| within        | be sold at the retail level, are contained within a multiunit package, the labels of the individual                 |
| within        | be sold at the retail level, are contained within a multiunit package, the labels of the individual                 |
| less than     | Intended For Individual Sale&#8221; in type size not less than  one-sixteenth inch in height.                       |
| before        | in paragraph (e)(1) of this section, on or before  May 21, 1986, or on or                                           |
| before        | in paragraph (e)(1) of this section, on or before  May 21, 1986, or on or                                           |
| before        | in paragraph (e)(1) of this section, on or before  May 21, 1986, or on or                                           |
| before        | address specified in paragraph (e)(1) of this section, before the first processing of the infant formula, the       |
| after         | (2)(i) If  after completing its review of all information submitted, the                                            |
| after         | labeling requirements of subpart B of this part. after                                                              |
| after         | nutrient, or labeling requirements is 60 calendar days after issuance of the final decision except as otherwise     |
| after         | apply only to those formulas that are manufactured after  the compliance date.                                      |
| after         | and Drug Administration Emergency Call Center at 866-300-4374. after                                                |
| less than     | contain the following nutrients at a level not less than the minimum level specified and not more than              |
| minimum       | nutrients at a level not less than the minimum level specified and not more than the maximum                        |
| more than     | less than the minimum level specified and not more than the maximum level specified for each 100 kilocalories       |
| maximum       | minimum level specified and not more than the maximum level specified for each 100 kilocalories of the              |
| at least      | E shall be present at a level of at least 0.7 International Unit of vitamin E per gram                              |
| at least      | B6 shall be present at a level of at least 15 micrograms of vitamin B6 for each gram                                |
| no less than  | consumption as directed on the container shall be no less than  1.1 and not more than 2.0.                          |
| more than     | shall be no less than 1.1 and not more than  2.0.                                                                   |
| not to exceed | (f) Protein shall be present in an amount  not to exceed 4.5 grams per 100 kilocalories regardless of quality,      |
| less than     | per 100 kilocalories regardless of quality, and not less than 1.8 grams per 100 kilocalories of infant formula      |
| less than     | If the biological quality of the protein is  less than that of casein, the minimum amount of protein                |
| minimum       | protein is less than that of casein, the minimum amount of protein shall be increased proportionately to            |
| at least      | quality of 75 percent of casein shall contain at least  2.4 grams of protein (1.8/0.75).                            |
| less than     | No protein with a biological quality  less than  70 percent of casein shall be used.                                |
| after         | notice shall be provided by the recalling firm after approval of the notice by the Food and                         |
| within        | to be recalled, the recalling firm shall telephone within 24 hours the appropriate Food and Drug Administration     |
| after         | Within 14 days  after the recall has begun, the recalling firm shall                                                |
| at least      | office a written status report on the recall at least  every 14 days until the recall is terminated.                |
| within        | The Agency will respond  within 15 days of receipt by the Division of                                               |
| after         | If  after a review of the recalling firm's recall strategy                                                          |
| at least      | Such records shall be retained for  at least 1 year after the expiration of the shelf                               |
| after         | shall be retained for at least 1 year after the expiration of the shelf life of the                                 |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                     |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 60.0 day   | (iii) The compliance date for the withdrawal of a product's exempt status or the imposition of additional or modified quality control, nutrient, or labeling requirements is 60 calendar days after issuance of the final decision except as otherwise provided for reasons stated in the decision.                         |
| 24.0 hour  | When a determination is made that an infant formula is to be recalled, the recalling firm shall telephone within 24 hours the appropriate Food and Drug Administration district office listed in &#167;&#8201;5.115 of this chapter and shall provide relevant information about the infant formula that is to be recalled. |
| 14.0 day   | Within 14 days after the recall has begun, the recalling firm shall provide a written report to the appropriate FDA district office.                                                                                                                                                                                        |
| 14.0 day   | The recalling firm shall submit to the appropriate FDA district office a written status report on the recall at least every 14 days until the recall is terminated.                                                                                                                                                         |
| 15.0 day   | The Agency will respond within 15 days of receipt by the Division of Enforcement of the request for termination.                                                                                                                                                                                                            |
| 1.0 year   | Such records shall be retained for at least 1 year after the expiration of the shelf life of the infant formula.                                                                                                                                                                                                            |


## Condition

| Condition      | Context                                                                                                                                |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------|
| subject to     | (d) An exempt infant formula is  subject to the provisions of &#167;&#8201;107.50 and other applicable Food                            |
| unless         | Regulations are to chapter I of title 21, unless  otherwise noted.                                                                     |
| when           | choline, and inositol content shall be declared except when  they are not added to milk-based infant formulas.                         |
| if             | &#8220;Infant Formula With Iron&#8221;, or a similar statement, if the product contains 1 milligram or more of                         |
| when           | a quantity of product that supplies 100 kilocalories when prepared in accordance with label directions for infant                      |
| if             | Iron May Be Necessary&#8221;, or a similar statement, if the product contains less than 1 milligram of                                 |
| when           | a quantity of product that supplies 100 kilocalories when prepared in accordance with label directions for infant                      |
| provided that  | minerals may be declared between iodine and sodium, provided that  any additionally declared nutrient:                                 |
| when           | considered in these publications as having biological significance, when  these levels are known.                                      |
| when           | Opening&#8221;; (3) &#8220;Sterilization&#8221; of water, bottle, and nipples when necessary for preparing infant formula for use; (4) |
| when           | Opening&#8221;; (3) &#8220;Sterilization&#8221; of water, bottle, and nipples when necessary for preparing infant formula for use; (4) |
| until          | or other information showing that the infant formula, until that date, under the conditions of handling, storage,                      |
| when           | and use prescribed by label directions, will: (1) when consumed, contain not less than the quantity of                                 |
| provided that  | and (b)(2) and 107.20 (b), (e), and (f), provided that (a) the multiunit package meets all the requirements                            |
| if             | otherwise has an unusual medical or dietary problem, if such formulas comply with regulations prescribed by the                        |
| when           | of an infant formula covered by this paragraph, when any change in ingredients or processes that may                                   |
| subject to     | those generally available at the retail level are subject to the requirements of paragraph (b) of this section                         |
| if             | and Applied Nutrition concludes that additional or mod if ied quality control, nutrient, or labeling requirements are                  |
| when           | decide that withdrawal of an exemption is necessary when , on the basis of its review under                                            |
| subject to     | or medical condition; (ii) For exempt infant formulas subject to paragraph (b) of this section, a deviation from                       |
| when           | shall promptly notify the Food and Drug Administration when the manufacturer has knowledge (as defined in section                      |
| subject to     | the manufacturer and that has left an establishment subject to the control of the manufacturer may not provide                         |
| when           | shall promptly notify the Food and Drug Administration when the manufacturer has knowledge (as defined in section                      |
| if             | (2) The manufacturer shall promptly not if y the Food and Drug Administration when the                                                 |
| when           | prepared for consumption as directed on the container when its biological quality is equivalent to or better                           |
| if             | to legal action, the manufacturer, upon prompt not if ication to FDA, shall administer such voluntary recall                           |
| not subject to | from the market an infant formula that is not subject to &#167;&#8201;107.200 but that otherwise violates the laws and                 |
| subject to     | the market an infant formula that is not subject to &#167;&#8201;107.200 but that otherwise violates the laws and                      |
| if             | withdrawal, as defined in &#167;&#8201;7.3(j) of this chapter. if                                                                      |
| subject to     | a minor way and that would not be subject to legal action, such removal from the market is                                             |
| when           | and (iii) Does not present a human risk. when                                                                                          |
| when           | and (iii) Does not present a human risk. when                                                                                          |
| subject to     | distributed infant formula that: (i) Is no longer subject to the manufacturer's control; (ii) Is in violation of                       |
| if             | its own health hazard evaluation and promptly not if y the recalling firm of the results of                                            |
| if             | into account the health hazard evaluation and spec if y the following: The extent of the recall;                                       |
| if             | a notice of such recall at such establishment. if                                                                                      |
| until          | each retail establishment maintain such notice on display until such time as the Food and Drug Administration                          |
| until          | on the recall at least every 14 days until  the recall is terminated.                                                                  |
| until          | firm shall continue to implement the recall strategy until it receives final written notification from the Agency                      |
| unless         | The Agency will send such notification,  unless the Agency has information from FDA's own audits                                       |
| if             | to: (a) Change the extent of the recall, if the agency concludes on the basis of available                                             |
| if             | (b) Carry out additional effectiveness checks,  if the agency's audits, or other information, demonstrate that                         |
| if             | (c) Issue additional not if ications to the firm's direct accounts,                                                                    |


## Entities

| Entities            | Context                                                                                                                     |
|:--------------------|:----------------------------------------------------------------------------------------------------------------------------|
| Food                | Food  and Drugs.                                                                                                            |
| Failure             | Failure to comply with any regulation in subpart B                                                                          |
| Failure             | Failure to comply with any regulations in subpart C                                                                         |
| Failure             | Failure to comply with any regulation in subpart D                                                                          |
| Exempt              | Exempt  formula.                                                                                                            |
| D, and E            | the declarations in International Units for vitamins A, D, and E , and immediately following the declarations in milligrams |
| Medicine            | Food and Nutrition Board of the Institute of Medicine through its development of a Dietary Reference Intake,                |
| Exempt              | Exempt infant formulas distributed directly to institutions such as                                                         |
| Food                | &#167;&#8201;10.75 by the office of the Commissioner of Food  and Drugs.                                                    |
| Nutrition, Labeling | for Food Safety and Applied Nutrition, Office of Nutrition, Labeling , and Dietary Supplements, Infant Formula and Medical  |
| Food                | Food  and Drug Administration-required recall.                                                                              |
| Scope               | Scope  and effect of infant formula recalls.                                                                                |
| Enforcement         | for transmittal to the Recall Coordinator, Division of Enforcement (HFS-605), Office of Compliance, Center for Food Safety  |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1986-05-21 | (3) To retain the exempt status of an infant formula covered by this paragraph, the manufacturer shall submit to the Food and Drug Administration (FDA), at the address specified in paragraph (e)(1) of this section, on or before May 21, 1986, or on or before the 90th day before the first processing of the infant formula for commercial or charitable distribution, whichever occurs later, the label and other labeling of the infant formula, a complete quantitative formulation for the infant formula, and a detailed description of the medical conditions for which the infant formula is represented. |


